Literature DB >> 12411428

Citron kinase is a cell cycle-dependent, nuclear protein required for G2/M transition of hepatocytes.

Huifei Liu1, Ferdinando Di Cunto, Sara Imarisio, Lola M Reid.   

Abstract

Citron Kinase (Citron-K) is a cell cycle-dependent protein regulating the G(2)/M transition in hepatocytes. Synchronization studies demonstrated that expression of the Citron-K protein starts at the late S and/or the early G(2) phase after that of cyclin B1. Expression of Citron-K is developmentally regulated. Levels of Citron-K mRNA and protein are highest in embryonic liver and gradually decrease after birth. Citron-K exists in interphase nuclei and begins to disperse into the cytoplasm at prophase. It concentrates at the cleavage furrow and midbody during anaphase, telophase, and cytokinesis, implicating a role in the control of cytokinesis. However, studies with knockouts show that Citron-K is not essential for cytokinesis in hepatocytes. Instead, loss of Citron-K causes a significant increase of G(2) tetraploid nuclei in one-week-old rat and mouse liver. In addition, Citron-K deficiency triggers apoptosis in a small subset of embryonic liver cells. In summary, our data demonstrate that Citron-K has a distinct cell cycle-dependent expression pattern and cellular localization as a downstream target of Rho-GTPase and functions in the control of G(2)/M transition in the hepatocyte cell cycle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411428     DOI: 10.1074/jbc.M210391200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Terminal cytokinesis events uncovered after an RNAi screen.

Authors:  Arnaud Echard; Gilles R X Hickson; Edan Foley; Patrick H O'Farrell
Journal:  Curr Biol       Date:  2004-09-21       Impact factor: 10.834

2.  RNA interference targeting CITRON can significantly inhibit the proliferation of hepatocellular carcinoma cells.

Authors:  Yinghui Fu; Jian Huang; Ke-Sheng Wang; Xin Zhang; Ze-Guang Han
Journal:  Mol Biol Rep       Date:  2010-04-06       Impact factor: 2.316

3.  Citron kinase, a RhoA effector, enhances HIV-1 virion production by modulating exocytosis.

Authors:  Rebecca J Loomis; Derek A Holmes; Andrew Elms; Patricia A Solski; Channing J Der; Lishan Su
Journal:  Traffic       Date:  2006-12       Impact factor: 6.215

4.  Drosophila sticky/citron kinase is a regulator of cell-cycle progression, genetically interacts with Argonaute 1 and modulates epigenetic gene silencing.

Authors:  Sarah J Sweeney; Paula Campbell; Giovanni Bosco
Journal:  Genetics       Date:  2008-02-01       Impact factor: 4.562

5.  Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma.

Authors:  Ilyas Sahin; Yawara Kawano; Romanos Sklavenitis-Pistofidis; Michele Moschetta; Yuji Mishima; Salomon Manier; Antonio Sacco; Ruben Carrasco; Rafael Fonseca; Aldo M Roccaro; Thomas Witzig; Irene M Ghobrial
Journal:  Blood Adv       Date:  2019-04-09

6.  ASPM and CITK regulate spindle orientation by affecting the dynamics of astral microtubules.

Authors:  Marta Gai; Federico T Bianchi; Cristiana Vagnoni; Fiammetta Vernì; Silvia Bonaccorsi; Selina Pasquero; Gaia E Berto; Francesco Sgrò; Alessandra Ma Chiotto; Laura Annaratone; Anna Sapino; Anna Bergo; Nicoletta Landsberger; Jacqueline Bond; Wieland B Huttner; Ferdinando Di Cunto
Journal:  EMBO Rep       Date:  2016-08-25       Impact factor: 8.807

7.  p27(Kip1) controls cytokinesis via the regulation of citron kinase activation.

Authors:  Murielle P Serres; Uta Kossatz; Yong Chi; James M Roberts; Nisar P Malek; Arnaud Besson
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

Review 8.  Human hepatic stem cell and maturational liver lineage biology.

Authors:  Rachael Turner; Oswaldo Lozoya; Yunfang Wang; Vincenzo Cardinale; Eugenio Gaudio; Gianfranco Alpini; Gemma Mendel; Eliane Wauthier; Claire Barbier; Domenico Alvaro; Lola M Reid
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

9.  Signaling through Rho GTPase pathway as viable drug target.

Authors:  Qun Lu; Frank M Longo; Huchen Zhou; Stephen M Massa; Yan-Hua Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 10.  Rho GTPases modulate malignant transformation of tumor cells.

Authors:  Jose L Orgaz; Cecilia Herraiz; Victoria Sanz-Moreno
Journal:  Small GTPases       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.